Achieving remission may be one goal of your treatment. In a clinical study, VENCLEXTA™ helped most people living with previously treated CLL with 17p deletion achieve some level of remission, or response to therapy. These responses included mostly partial remissions and some complete remissions. Response types in this study included:

  • Partial remission means the cancer is greatly improved and there are fewer cancer cells, but evidence of the cancer is still in your body
  • Nodular partial remission means that most signs and symptoms of cancer disappeared for a period of time except for some remaining cancer cells in your bone marrow
  • Complete remission means that all signs and symptoms of cancer disappeared for a period of time, although cancer may still be in your body
  • Complete remission with incomplete marrow recovery means that most signs and symptoms of cancer disappeared for a period of time except that platelet, white blood cell, or red blood cell counts remained low
CLL with 17p deletion image: 4 out of 5 people who took VENCLEXTA achieved some level of remission

Select Important Safety Information

The most common side effects of VENCLEXTA include low white blood cell count, diarrhea, nausea, low red blood cell count, upper respiratory tract infection, low platelet count, and feeling tired.

VENCLEXTA may cause fertility problems in males. This may affect your ability to father a child. Talk to your doctor if you have concerns about fertility.

These are not all the possible side effects of VENCLEXTA. Tell your doctor if you have any side effect that bothers you or that does not go away.